Quest Diagnostics Incorporated (DGX)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Oct 20, 2026
Consensus estimate row
EPS target
$2.85
Street estimate
Revenue target
$3.04B
Street estimate
Trailing EPS (avg 4Q)
$2.66
Beat rate last 4: 100%
Latest EPS YoY
+19.1%
vs 2025-07-22
Latest revenue YoY
+10.2%
How results look so far
Trailing revenue (avg 4Q)
$2.89B
Printed quarters
EPS beat rate (4Q)
100%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Jul 23, 2026
EPS beat
EPS actual / est
$3.12 / $2.82
+10.6%
Revenue actual / est
$3.04B / $2.97B
+2.4%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 10/20/2026upcoming | $2.85 | Pending | — | $3.04B | Pending | — |
| 7/28/2026upcoming | $2.81 | Pending | — | $2.98B | Pending | — |
| 7/23/2026 | $2.82 | $3.12 | +10.6% | $2.97B | $3.04B | +2.4% |
| 4/21/2026 | $2.37 | $2.50 | +5.5% | $2.83B | $2.90B | +2.3% |
| 2/10/2026 | $2.36 | $2.42 | +2.5% | $2.75B | $2.81B | +1.9% |
| 10/21/2025 | $2.50 | $2.60 | +4.0% | $2.74B | $2.82B | +2.9% |
| 7/22/2025 | $2.57 | $2.62 | +1.9% | $2.73B | $2.76B | +1.3% |
| 4/22/2025 | $2.15 | $2.21 | +2.8% | $2.63B | $2.65B | +0.8% |
| 1/30/2025 | $2.19 | $2.23 | +1.8% | $2.58B | $2.62B | +1.6% |
| 10/22/2024 | $2.26 | $2.30 | +1.8% | $2.43B | $2.49B | +2.3% |
| 7/23/2024 | $2.34 | $2.35 | +0.4% | $2.39B | $2.40B | +0.3% |
| 4/23/2024 | $1.86 | $2.04 | +9.7% | $2.29B | $2.37B | +3.5% |
| 2/1/2024 | $2.11 | $2.15 | +1.9% | $2.25B | $2.29B | +1.5% |
| 10/24/2023 | $2.19 | $2.22 | +1.4% | $2.27B | $2.29B | +1.0% |
| 7/26/2023 | $2.27 | $2.30 | +1.3% | $2.25B | $2.34B | +3.7% |
| 4/27/2023 | $1.97 | $2.04 | +3.6% | $2.20B | $2.33B | +6.1% |
| 2/2/2023 | $1.90 | $1.98 | +4.2% | $2.26B | $2.33B | +3.4% |
| 10/20/2022 | $2.19 | $2.36 | +7.8% | $2.35B | $2.49B | +5.9% |
| 7/21/2022 | $2.29 | $2.36 | +3.1% | $2.34B | $2.45B | +4.8% |
| 4/21/2022 | $2.97 | $3.22 | +8.4% | $2.64B | $2.61B | -1.0% |
Need DGX data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.